Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

43.55
Delayed Data
As of Aug 26
 -0.19 / -0.43%
Today’s Change
36.71
Today|||52-Week Range
45.58
+9.47%
Year-to-Date
3 High-Yield Dividend Stocks to Buy in September
9:10am / MotleyFool.com - Paid Partner Content
Glaxo/Pfizer ViiV Healthcare Starts HIV Drug Combo Study
Aug 17 / Zacks.com - Paid Partner Content
Can Novartis Tide Over the Alcon Crisis?
Aug 26 / GuruFocus News - Paid Partner Content
Inovio Expands Enrollment in Ebola Vaccine Phase I Study
Aug 15 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: GlaxoSmithKline, Blackstone Group, Mylan, Lululemo...
Aug 26 / Zacks.com - Paid Partner Content
Bristol-Myers' Revolutionary Cancer Drug Suffers A Big Blow
Aug 14 / MotleyFool.com - Paid Partner Content
Top Research Reports for August 25, 2016
Aug 25 / Zacks.com - Paid Partner Content
Struggling in China, foreign firms seek to become more Chinese
Aug 02 / CNNMoney.com
Henderson Revises Global Dividend Expectations Lower For 2016
Aug 22 / TheStreet.com - Paid Partner Content
Google partners with GlaxoSmithKline on $700 million 'bioelectronic' venture
Aug 01 / CNNMoney.com
Teva Cinqaero Gets EU Nod for Severe Eosinophilic Asthma
Aug 19 / Zacks.com - Paid Partner Content